{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:09:20Z","timestamp":1790284160308,"version":"4.1.0"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:p>\n                    Monogenic diabetes is a category of diabetes mellitus caused by a single gene mutation or chromosomal abnormality, usually sub-classified as either neonatal diabetes or maturity-onset diabetes of the young (MODY). Although monogenic diabetes affects up to 3.5% of all patients with diabetes diagnosed before age 30, misdiagnosis and\/or improper treatment occurs frequently. The University of Chicago Monogenic Diabetes Registry, established in 2008, offers insight into the diagnosis, treatment, and natural history of individuals known or suspected to have monogenic diabetes. Those interested in participating in the Registry begin by completing a secure web-based registration form found on our website (\n                    <jats:uri>http:\/\/monogenicdiabetes.uchicago.edu\/registry\/<\/jats:uri>\n                    ). Participants are then screened for eligibility and consented either by phone, video call, or in person. Relevant medical and family history is collected at baseline and then annually\n                    <jats:italic>via<\/jats:italic>\n                    surveys through our secure Research Electronic Data Capture (REDCap) database. The University of Chicago Monogenic Diabetes Registry has enrolled over 3800 participants from over 2000 families. Participants represent all 50 states and more than 20 different countries. To date, over 1100 participants have a known genetic cause of diabetes. While many Registry participants reported being referred through their diabetes care provider (54%), a large portion also learned about the Registry through web searching (24%), friends\/family (18%), or other sources (13%). Around two-thirds of those with a known genetic cause had research-based genetic testing completed rather than clinical testing due to insurance coverage difficulties. Of those who were found to have monogenic diabetes, significant delays in diagnosis were identified, which highlights the need for increased access to clinical genetic testing covered by insurance companies specifically within the United States. Among genes that cause a MODY phenotype,\n                    <jats:italic>GCK<\/jats:italic>\n                    mutations were the most common (59%) followed by\n                    <jats:italic>HNF1A<\/jats:italic>\n                    mutations (28%), while mutations in\n                    <jats:italic>KCNJ11<\/jats:italic>\n                    were the most common among genes that cause neonatal diabetes (35%) followed by\n                    <jats:italic>INS<\/jats:italic>\n                    (16%). Over the last decade, improvements in data collection for the University of Chicago Monogenic Diabetes Registry have resulted in increased knowledge of the natural history of monogenic diabetes, as well as a better understanding of the most effective treatments. The University of Chicago Monogenic Diabetes Registry serves as a valuable resource that will continue to provide evidence to support improved clinical care and patient outcomes in monogenic diabetes.\n                  <\/jats:p>","DOI":"10.3389\/fcdhc.2021.735548","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T08:49:47Z","timestamp":1636102187000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry"],"prefix":"10.3389","volume":"2","author":[{"given":"Tiana L.","family":"Bowden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Letourneau-Freiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balamurugan","family":"Kandasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Sanyoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Persephone","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia G.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme I.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis H.","family":"Philipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle N.","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri Atma W.","family":"Greeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0224","article-title":"Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients","volume":"40","author":"Shields","year":"2017","journal-title":"Diabetes Care"},{"key":"B2","volume-title":"Online Mendelian Inheritance in Man, OMIM\u00ae","year":""},{"key":"B3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11892-018-1016-2","article-title":"Congenital Diabetes: Comprehensive Genetic Testing Allows for Improved Diagnosis and Treatment of Diabetes and Other Associated Features","volume":"18","author":"Letourneau","year":"2018","journal-title":"Curr Diabetes Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1406261","article-title":"ClinGen The Clinical Genome Resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/193229681100500409","article-title":"Creation of the Web-Based University of Chicago Monogenic Diabetes Registry: Using Technology to Facilitate Longitudinal Study of Rare Subtypes of Diabetes","volume":"5","author":"Greeley","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2008.00433.x","article-title":"Diagnosis and Treatment of Neonatal Diabetes: A United States Experience","volume":"9","author":"St\u00f8y","year":"2008","journal-title":"Pediatr Diabetes"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2014A Metadata-Driven Methodology and Workflow Process for Providing Translational Research Informatics Support","volume":"42","author":"Harris","year":"2009","journal-title":"J BioMed Inform"},{"key":"B9","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap Consortium: Building an International Community of Software Partners","volume":"95","author":"Harris","year":"2019","journal-title":"J BioMed Inform"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2015.06.013","article-title":"An Online Monogenic Diabetes Discussion Group: Supporting Families and Fueling New Research","volume":"166","author":"Perrone","year":"2015","journal-title":"Transl Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60098-8","article-title":"The Effect of Early, Comprehensive Genomic Testing on Clinical Care in Neonatal Diabetes: An International Cohort Study","volume":"386","author":"De Franco","year":"2015","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/jgc4.1078","article-title":"Racial and Ethnic Differences in Knowledge and Attitudes About Genetic Testing in the US: Systematic Review","volume":"28","author":"Canedo","year":"2019","journal-title":"J Genet Couns"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2017.11.001","article-title":"Direct-To-Consumer Testing 2.0: Emerging Models of Direct-To-Consumer Genetic Testing","volume":"93","author":"Allyse","year":"2018","journal-title":"Mayo Clin Proc"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2021.735548\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T08:49:50Z","timestamp":1636102190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2021.735548\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":13,"alternative-id":["10.3389\/fcdhc.2021.735548"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2021.735548","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"article-number":"735548"}}